• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清对氧磷酶 1 活性降低可作为严重冠状动脉疾病的标志物。

Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.

机构信息

Department of Biochemistry and Molecular Biology, Wuhan University School of Medicine, Wuhan, Hubei 430071, China.

出版信息

Dis Markers. 2013;35(2):97-103. doi: 10.1155/2013/816189. Epub 2013 Jul 28.

DOI:10.1155/2013/816189
PMID:24167353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3774974/
Abstract

Paraoxonase-1 (PON1), a high-density-lipoprotein- (HDL-) associated enzyme, has the potential to protect against atherogenesis. We examine the relationships between plasma PON1 activity and the progression of atherosclerosis as well as coronary artery disease (CAD). Fasting blood samples were collected from female apolipoprotein E-deficient (apoE(-/-)) mice and 149 patients undergoing coronary angiography for the biochemical parameters measurement. The severity of CAD was defined using angiographic Gensini score (GSS). Compared to 3-month-old apoE(-/-) mice, aged mice had significantly lower PON1 activity, which is negatively correlated with the size of atherosclerotic lesion and plasma interleukin-6 (IL-6) and tumor necrosis factor α (TNF- α ) levels. In study patients, PON1 activity was correlated with age, sex, and HDL-cholesterol, apolipoprotein AI, and high-sensitivity C-reactive protein (hs-CRP) levels and was significantly lower in CAD group than that in non-CAD control group. Interestingly, PON1 activity in severe CAD group (GSS > 40) was further significantly reduced compared to those in mild and moderate subgroups (GSS  ≤ 40) (P < 0.01). There is a significant correlation between PON1 activity and the severity of CAD as assessed by GSS (r = -0.393, P < 0.001). PON1 activity may be a potential biomarker for the severity of CAD.

摘要

对氧磷酶 1(PON1)是一种高密度脂蛋白(HDL)相关的酶,具有防止动脉粥样硬化形成的潜力。我们研究了血浆 PON1 活性与动脉粥样硬化进展以及冠心病(CAD)之间的关系。从进行冠状动脉造影的女性载脂蛋白 E 缺陷(apoE(-/-))小鼠和 149 例患者中采集空腹血样,用于生化参数测量。CAD 的严重程度采用血管造影 Gensini 评分(GSS)定义。与 3 月龄 apoE(-/-)小鼠相比,老龄小鼠的 PON1 活性显著降低,且与动脉粥样硬化病变的大小以及血浆白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)水平呈负相关。在研究患者中,PON1 活性与年龄、性别以及 HDL-胆固醇、载脂蛋白 AI 和高敏 C 反应蛋白(hs-CRP)水平相关,且在 CAD 组中显著低于非 CAD 对照组。有趣的是,与轻度和中度亚组(GSS≤40)相比,严重 CAD 组(GSS>40)的 PON1 活性进一步显著降低(P<0.01)。PON1 活性与 GSS 评估的 CAD 严重程度之间存在显著相关性(r=-0.393,P<0.001)。PON1 活性可能是 CAD 严重程度的潜在生物标志物。

相似文献

1
Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.血清对氧磷酶 1 活性降低可作为严重冠状动脉疾病的标志物。
Dis Markers. 2013;35(2):97-103. doi: 10.1155/2013/816189. Epub 2013 Jul 28.
2
Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality.通过替代载脂蛋白 1 活性来评估冠心病风险:基于高密度脂蛋白功能的新型代谢相关心血管生物标志物。
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):1166-1176. doi: 10.1016/j.numecd.2020.12.026. Epub 2021 Jan 1.
3
Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease.对氧磷酶-1活性和浓度与冠状动脉疾病血管造影严重程度及范围的关联
J Am Coll Cardiol. 2006 Jun 20;47(12):2429-35. doi: 10.1016/j.jacc.2006.01.074. Epub 2006 May 26.
4
Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.低对氧磷酶1芳基酯酶活性和高血管性血友病因子水平与非糖尿病稳定型冠心病患者的严重冠状动脉粥样硬化相关。
Med Sci Monit. 2014 Nov 25;20:2421-9. doi: 10.12659/MSM.890911.
5
Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.血清髓过氧化物酶/对氧磷酶1比值作为冠状动脉疾病中功能失调的高密度脂蛋白和风险分层的潜在指标。
Atherosclerosis. 2014 Jun;234(2):288-94. doi: 10.1016/j.atherosclerosis.2014.03.009. Epub 2014 Mar 19.
6
Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.印度西北部患有冠状动脉疾病和2型糖尿病的旁遮普人的对氧磷酶(PON1)活性
Indian J Med Res. 2007 Jun;125(6):783-7.
7
Low serum paraoxonase1 activity levels predict coronary artery disease severity.血清对氧磷酶1活性水平低预示冠状动脉疾病的严重程度。
Oncotarget. 2017 Mar 21;8(12):19443-19454. doi: 10.18632/oncotarget.14305.
8
Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.对氧磷酶-1 基因型和活性均不能预测未来患冠状动脉疾病的风险;EPIC-诺福克前瞻性人群研究。
PLoS One. 2009 Aug 27;4(8):e6809. doi: 10.1371/journal.pone.0006809.
9
Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.安塔利亚地区经血管造影证实患有冠状动脉疾病的人群中对氧磷酶-1活性与脂质过氧化指标水平之间的关联。
Clin Cardiol. 2004 Jul;27(7):426-30. doi: 10.1002/clc.4960270714.
10
Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.2型糖尿病患者中载脂蛋白A-I糖基化升高与高密度脂蛋白相关对氧磷酶1、3活性降低的关联及其与冠状动脉疾病血管造影严重程度的相互作用。
Cardiovasc Diabetol. 2015 May 13;14:52. doi: 10.1186/s12933-015-0221-4.

引用本文的文献

1
miR-122/PPARβ axis is involved in hypoxic exercise and modulates fatty acid metabolism in skeletal muscle of obese rats.微小RNA-122/过氧化物酶体增殖物激活受体β轴参与低氧运动并调节肥胖大鼠骨骼肌中的脂肪酸代谢。
Heliyon. 2024 Feb 20;10(4):e26572. doi: 10.1016/j.heliyon.2024.e26572. eCollection 2024 Feb 29.
2
Novel lipid biomarkers and associated gene polymorphism in young ST-segment elevation myocardial infarction.年轻的 ST 段抬高型心肌梗死中的新型脂质生物标志物及相关基因多态性
Indian Heart J. 2023 Jan-Feb;75(1):68-72. doi: 10.1016/j.ihj.2022.11.014. Epub 2022 Nov 26.
3
Importance of Polymorphisms in the Gene of Paraoxonase-1 (SNP rs662) and Apolipoprotein A-I (SNP rs670 and rs5069) in Non-Smoking and Smoking Healthy Subjects and Patients with Acute Pancreatitis.

本文引用的文献

1
Paraoxonase 1 and homocysteine metabolism.对氧磷酶 1 与同型半胱氨酸代谢。
Amino Acids. 2012 Oct;43(4):1405-17. doi: 10.1007/s00726-012-1321-z. Epub 2012 May 29.
2
Quantitative assessment of the influence of paraoxonase 1 activity and coronary heart disease risk.定量评估对氧磷酶 1 活性和冠心病风险的影响。
DNA Cell Biol. 2012 Jun;31(6):975-82. doi: 10.1089/dna.2011.1478. Epub 2012 Feb 9.
3
Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies.载脂蛋白 PON1 活性与冠心病风险的关联:基于 43 项研究的荟萃分析。
载脂蛋白 A-I (SNP rs670 和 rs5069) 和对氧磷酶 1 基因 (SNP rs662) 多态性在非吸烟和吸烟健康受试者及急性胰腺炎患者中的重要性。
Genes (Basel). 2022 Oct 28;13(11):1968. doi: 10.3390/genes13111968.
4
Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice.肝脏对氧磷酶1改善I型清道夫受体缺陷小鼠中功能失调的高密度脂蛋白及动脉粥样硬化。
Ann Transl Med. 2021 Jul;9(13):1063. doi: 10.21037/atm-21-682.
5
The Antioxidant Enzyme PON1: A Potential Prognostic Predictor of Acute Ischemic Stroke.抗氧化酶 PON1:急性缺血性脑卒中的潜在预后预测因子。
Oxid Med Cell Longev. 2021 Feb 5;2021:6677111. doi: 10.1155/2021/6677111. eCollection 2021.
6
Assessment of Serum Lipid Profiles and High-sensitivity C-reactive Protein Among Patients Suffering from Rheumatoid Arthritis at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study.埃塞俄比亚亚的斯亚贝巴提库尔安贝萨专科医院类风湿关节炎患者血清脂质谱和高敏C反应蛋白的评估:一项横断面研究
Open Access Rheumatol. 2020 Sep 23;12:223-232. doi: 10.2147/OARRR.S264466. eCollection 2020.
7
Inhibition of miR-27b Regulates Lipid Metabolism in Skeletal Muscle of Obese Rats During Hypoxic Exercise by Increasing PPARγ Expression.抑制miR-27b通过增加PPARγ表达调节肥胖大鼠低氧运动期间骨骼肌的脂质代谢。
Front Physiol. 2020 Aug 31;11:1090. doi: 10.3389/fphys.2020.01090. eCollection 2020.
8
Decreases in Paraoxonase-1 Activities Promote a Pro-inflammatory Effect of Lipids Peroxidation Products in Non-smoking and Smoking Patients with Acute Pancreatitis.对非吸烟和吸烟的急性胰腺炎患者,对氧磷酶-1 活性降低促进了脂质过氧化产物的促炎作用。
Int J Med Sci. 2018 Oct 20;15(14):1619-1630. doi: 10.7150/ijms.27647. eCollection 2018.
9
Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice.载脂蛋白代谢相关蛋白标志物在清道夫受体 B Ⅰ型缺陷小鼠模型中的变化。
J Transl Med. 2018 Jun 7;16(1):155. doi: 10.1186/s12967-018-1502-y.
10
Relationship between rs854560 Gene Polymorphism and Tobacco Smoking with Coronary Artery Disease.rs854560 基因多态性与冠心病及吸烟的关系。
Dis Markers. 2017;2017:1540949. doi: 10.1155/2017/1540949. Epub 2017 Sep 29.
Mol Genet Metab. 2012 Jan;105(1):141-8. doi: 10.1016/j.ymgme.2011.09.018. Epub 2011 Sep 22.
4
PON-dering differences in HDL function in coronary artery disease.思考在冠心病中 HDL 功能的差异。
J Clin Invest. 2011 Jul;121(7):2545-8. doi: 10.1172/JCI57671. Epub 2011 Jun 23.
5
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.冠心病患者中 HDL 对 eNOS 激活途径产生不良影响的机制。
J Clin Invest. 2011 Jul;121(7):2693-708. doi: 10.1172/JCI42946. Epub 2011 Jun 23.
6
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.甘油三酯与心血管疾病:美国心脏协会的科学声明
Circulation. 2011 May 24;123(20):2292-333. doi: 10.1161/CIR.0b013e3182160726. Epub 2011 Apr 18.
7
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.高密度脂蛋白与心血管疾病:致病和保护机制。
Nat Rev Cardiol. 2011 Apr;8(4):222-32. doi: 10.1038/nrcardio.2010.222. Epub 2011 Feb 8.
8
Distribution of C-reactive protein and its association with cardiovascular risk factors in a population-based sample of Chinese.中国人群中 C 反应蛋白的分布及其与心血管危险因素的关系。
Dis Markers. 2010;28(6):333-42. doi: 10.3233/DMA-2010-0713.
9
Anti-inflammatory properties of paraoxonase-1 in atherosclerosis.对氧磷酶 1 在动脉粥样硬化中的抗炎作用。
Adv Exp Med Biol. 2010;660:143-51. doi: 10.1007/978-1-60761-350-3_13.
10
Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis.载脂蛋白 1(PON1)缺乏症的小鼠存在巨噬细胞 SR-BI 表达减少,从而导致 HDL 对细胞凋亡的保护作用丧失。
Atherosclerosis. 2010 Jul;211(1):61-8. doi: 10.1016/j.atherosclerosis.2010.01.025. Epub 2010 Jan 28.